[Laboratory monitoring of efficiency of different approaches to the therapy of patients with inhibitor form of haemophilia A].
Revealing of inhibitors form of hemophilia A form patients of hemophilia in Republic of Uzbekistan was studied and peculiarities of this form of hemophilia also was studied. Shown, that revealing of inhibitors form from 405 patients of hemophilia A was 7,7%. Shown that from patients with inhibitors form more patients with low titr of inhibitors (77,1%). In patients with high titr of inhibitors in high degree was more heavy degree of hemophilia A, in patients with low titr of inhibitors more heavy form and heavy form of hemophilia A was in equal degree. Shown, that Cogenait drug and plasmapheresis in Pph-3 - Pph-5 regime render equal effect in reducing of inhibitor titr.
Nabieva
M I
MI
D000293:Adolescent; D000328:Adult; D019774:Blood Coagulation Factor Inhibitors / Q000097:blood*; D001780:Blood Coagulation Tests / Q000379:methods; D002648:Child; D002675:Child, Preschool; D003029:Coagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D003627:Data Interpretation, Statistical; D005169:Factor VIII / Q000037:antagonists & inhibitors; D015944:Factor VIIIa / Q000008:administration & dosage / Q000627:therapeutic use*; D006467:Hemophilia A / Q000097:blood* / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D008875:Middle Aged; D010956:Plasmapheresis; D012720:Severity of Illness Index; D014610:Uzbekistan / Q000453:epidemiology; D055815:Young Adult
D019774:Blood Coagulation Factor Inhibitors; D003029:Coagulants; D015944:Factor VIIIa; D005169:Factor VIII